{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:21:20Z","timestamp":1776111680508,"version":"3.50.1"},"reference-count":14,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2022,6,5]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Changes in legislation due to COVID-19 led to the introduction of telemedicine for early medical abortion (EMA) at home in Scotland. The opportunity to provide contraception at presentation may be more limited with this model of care. We compared contraceptive use immediately post-abortion with 3\u20136 months later to determine if contraceptive needs were being met.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We contacted 579\u2009women by telephone call or text message who agreed to be involved in a service evaluation of telemedicine EMA in NHS Lothian at 3\u20136 months post-abortion. A research nurse administered a questionnaire on the women's current contraception use. The research nurses also offered women support in switching or initiating contraception via the abortion service if desired.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The response rate to the contact was 57% (331\/579). Under a third of the women (30%, 98\/331) were using the progestogen-only pill (POP) at 3\u20136\u2009month follow-up, a significant decrease (p&lt;0.00) compared with 65% (215\/331) who were provided with POP at the time of abortion. Thirty-nine\u2009women (12%) were provided with contraception through this telephone contact, leading to a significant increase in the proportion using subdermal implants, the progestogen injectable or intrauterine contraception.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study shows that there was a decrease in the use of the POP 3\u20136 months after telemedicine EMA during the COVID-19 pandemic. Telephone contact at 3\u20136 months to facilitate obtaining contraception may be a promising strategy to improve access to effective methods with this model of abortion care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjsrh-2022-201493","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T13:25:15Z","timestamp":1656681915000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Self-reported contraceptive use and satisfaction among women accessing telemedicine medical abortion at the onset of the COVID-19 pandemic at 3\u20136-month follow-up"],"prefix":"10.1136","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-9061","authenticated-orcid":false,"given":"Margherita","family":"Vianello","sequence":"first","affiliation":[{"name":"Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6597-1666","authenticated-orcid":false,"given":"John Joseph","family":"Reynolds-Wright","sequence":"additional","affiliation":[{"name":"Queen's Medical Research Institute, MRC Centre for Reproductive Health, The University of Edinburgh, Edinburgh, UK"},{"name":"Chalmers Centre, NHS Lothian, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-2276","authenticated-orcid":false,"given":"Sharon","family":"Cameron","sequence":"additional","affiliation":[{"name":"Queen's Medical Research Institute, MRC Centre for Reproductive Health, The University of Edinburgh, Edinburgh, UK"},{"name":"Chalmers Centre, NHS Lothian, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2025090510581032000_49.1.21.1","unstructured":"Scottish Government \u2013 Chief Medical Officer Directorate . Abortion \u2013 Covid-19 \u2013 Approval for Mifepristone to be Taken at Home and Other Contingency Measures, 2020. Available: https:\/\/www.sehd.scot.nhs.uk\/cmo\/CMO%282020%2909.pdf [Accessed 23 Apr 2021]."},{"key":"2025090510581032000_49.1.21.2","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG) . Coronavirus (COVID-19) infection and abortion care, 2020. Available: https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/coronavirus-abortion\/ [Accessed 23 Apr 2021]."},{"key":"2025090510581032000_49.1.21.3","unstructured":"Faculty of Sexual & Reproductive Healthcare (FSRH) . FSRH Position: Essential SRH services during COVID-19 March 2020, 2020. Available: https:\/\/www.fsrh.org\/documents\/fsrh-position-essential-srh-services-during-covid-19-march-2020\/ [Accessed 20 Apr 2021]."},{"key":"2025090510581032000_49.1.21.4","unstructured":"Faculty of Sexual & Reproductive Healthcare (FSRH) . FSRH COVID-19 SRH Service Survey - interim results 07 May 2020, 2020. Available: https:\/\/www.fsrh.org\/documents\/covid-19-fsrh-survey-interim-results-07-may-2020\/ [Accessed 20 Apr 2021]."},{"key":"2025090510581032000_49.1.21.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048948"},{"key":"2025090510581032000_49.1.21.6","unstructured":"Public Health Scotland . Termination of pregnancy statistics. Year ending 2019, 2022. Available: https:\/\/beta.isdscotland.org\/find-publications-and-data\/population-health\/sexual-health\/termination-of-pregnancy-statistics\/ [Accessed 27 Apr 2022]."},{"key":"2025090510581032000_49.1.21.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200976"},{"key":"2025090510581032000_49.1.21.8","unstructured":"Scottish Index of Multiple Deprivation (SIMD) . Scottish Index of Multiple Deprivation 2020, 2020. Available: http:\/\/simd.scot\/ [Accessed 07 Jun 2021]."},{"key":"2025090510581032000_49.1.21.9","unstructured":"Scottish Government . Scottish Index of Multiple Deprivation 2020. Available: https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/?utm_source=redirect&utm_medium=shorturl&utm_campaign=simd [Accessed 8 Jun 2021]."},{"key":"2025090510581032000_49.1.21.10","unstructured":"National Health Service (NHS) . How effective is contraception at preventing pregnancy? Your contraception guide, 2020. Available: https:\/\/www.nhs.uk\/conditions\/contraception\/how-effective-contraception\/ [Accessed 5 Apr 2021]."},{"key":"2025090510581032000_49.1.21.11","unstructured":"World Health Organization (WHO) . Family planning\/contraception methods, 2020. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/family-planning-contraception [Accessed 11 May 2022]."},{"key":"2025090510581032000_49.1.21.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2017-101818"},{"key":"2025090510581032000_49.1.21.13","unstructured":"Medicines and Healthcare Products Regulatory Agency . First progestogen-only contraceptive pills to be available to purchase from pharmacies, 2021. Available: https:\/\/www.gov.uk\/government\/news\/first-progesterone-only-contraceptive-pills-to-be-available-to-purchase-from-pharmacies [Accessed 18 Aug 2021]."},{"key":"2025090510581032000_49.1.21.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200610"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2022-201493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:22:48Z","timestamp":1757096568000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2022-201493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,10]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/bmjsrh-2022-201493"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2022-201493","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}